Home » Topics » Regulatory » Patents

Patents
RSS

Eli Lilly discloses new cannabinoid CB2 receptor agonists

Oct. 31, 2011

Novel transient receptor potential TRPV4 channel antagonists prepared by GSK

Oct. 31, 2011

Researchers at Abbott claim novel inhibitors of Bcl-2

Oct. 28, 2011

New Toll-like receptor 2 agonists prepared by IRM

Oct. 28, 2011

Marina Biotech presents novel nucleic acid complexes

Oct. 28, 2011

TopoTarget patents new nicotinamide phosphoribosyltransferase inhibitors

Oct. 28, 2011

New Wnt signaling inhibitors discovered in Germany

Oct. 28, 2011

Novel vasopressin V1A receptor antagonists designed by Roche

Oct. 28, 2011

New TRPV4 channel antagonists disclosed

Oct. 28, 2011

Ajinomoto prepares novel calcium-sensing CaS receptor agonists

Oct. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...